Sustainability by Design in API Manufacturing

Andrea is currently a manager in process development at the Madison, WI site. An organic chemist by training, she spent many years in the lab before changing roles to manage a team of chemists. She is experienced in process transfer for antibody-drug conjugate programs and small molecule APIs. After training for a graduate degree in asymmetric epoxidation, Andrea did post-doctoral work in the field of gold nanoparticle synthesis.

Robert is an associate director of R&D, working on new process technology including processing equipment, simulation software, and data acquisition projects that drive efficiency and capacity. Starting at our Sheboygan site and later transitioning to Madison’s HPAPI location, he has worked on improving chemical processes for 7 years after receiving his B.S. in chemical engineering from Case Western Reserve University.

Tobias is a director of process and analytical development at our center of excellence for drug delivery compounds in Schaffhausen, Switzerland. With 20+ years of experience in the pharmaceutical industry, Tobias leverages his broad expertise in process development, technology transfers, scale-up, GMP manufacturing, analytical development and project management to support our CDMO service offerings. He holds a doctoral degree in Chemistry from the University of Konstanz, Germany.

Bertram Cezanne heads process development synthesis within the electronics business of Merck. A chemist by training, he holds a Ph.D. in synthetic organic chemistry. In 1997, he joined Merck and worked for more than 15 years in drug discovery and early scale-up, where he gained broad experience in synthetic organic chemistry at different scales. Since 2016, he has been responsible for process development and supply of APIs, intermediates, and excipients during the development phase until launch and commercial manufacturing.